Loading...
Pharmacoproteomics identifies combinatorial therapy targets for diffuse large B cell lymphoma
Rationally designed combinations of targeted therapies for refractory cancers, such as activated B cell–like diffuse large B cell lymphoma (ABC DLBCL), are likely required to achieve potent, durable responses. Here, we used a pharmacoproteomics approach to map the interactome of a tumor-enriched iso...
Na minha lista:
Udgivet i: | J Clin Invest |
---|---|
Main Authors: | , , , , , , , , , , , |
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
American Society for Clinical Investigation
2015
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4665772/ https://ncbi.nlm.nih.gov/pubmed/26529251 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI80714 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|